• No results found

Non valvular atrial fibrillation

Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians

Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians

... or non-central nervous system thromboembolism doubled; ENGAGE AF-TIMI 48, Evaluation of Efficacy and Safety of Edoxaban versus Warfarin in Subjects with Atrial Fibrillation – Effective ...

13

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes

... Abstract: Atrial fibrillation is the most common arrhythmia worldwide, and carries a signifi- cantly increased risk of thromboembolic ...with non- valvular atrial ...

11

Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol

Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol

... of non-valvular atrial fibrillation (NVAF) in ...of atrial fibrillation, the methodology is limited, and the perspectives of Chinese experts and patients are ...

10

Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)

Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)

... Vitamin K antagonist like warfarin is recommended for years 1-3 for prevention of stroke in high risk non-valvular Atrial Fibrillation (AF) patients. Its benefits are related to achieving an ...

5

Original Article Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation

Original Article Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation

... Abstract: Despite potential advantages of warfarin in reducing stroke risk, the percentage of patients with non- valvular atrial fibrillation (NVAF) using warfarin is relatively low. Our aim ...

9

Characteristics of Pulmonary Vein Enlargement in Non Valvular Atrial Fibrillation Patients with Stroke

Characteristics of Pulmonary Vein Enlargement in Non Valvular Atrial Fibrillation Patients with Stroke

... in non-valvular atrial fibrillation (AF) patients remains ...and non- valvular AF patients without (AF group, n=138) and with non-hemorrhagic stroke (AF with stroke group, ...

11

Original Article CHA2DS2-VASc can better predict short-term prognosis in acute ischemic stroke patients with non-valvular atrial fibrillation

Original Article CHA2DS2-VASc can better predict short-term prognosis in acute ischemic stroke patients with non-valvular atrial fibrillation

... with non-valvular atrial fibrillation (NVAF) in elderly ...with non-valvular atrial fibrillation were enrolled in this ...with non-valvular ...

7

Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study

Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study

... Non-valvular atrial fibrillation (NVAF) is the most prevalent arrhythmia in the elderly and poses substantial morbidity and mortality risks because of an increase in cardiogenic thromboembolic ...

7

Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation?

Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation?

... and non- indexed LA measurements (AP diameter, area 4C, ellips- oid volume, 1P area-length volume and 2P area-length volume) to identify TEE surrogate markers of stroke (LAA thrombus, LAA low flow velocities, ...

12

Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation

<p>Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation</p>

... with non-valvular atrial fi brillation (NVAF) according to the 2019 American College of Cardiology guidelines for the management of atrial fi ...

9

Management of non-valvular Atrial Fibrillation

Management of non-valvular Atrial Fibrillation

... Atrial fibrillation (AF) affects about 1.2% of the population in the United Kingdom and accounts for about a sixth of all strokes. AF is the most common sustained cardiac arrhythmia and if left untreated AF ...

25

Characteristics affecting oral anticoagulant therapy choice among patients with non valvular atrial fibrillation: a retrospective claims analysis

Characteristics affecting oral anticoagulant therapy choice among patients with non valvular atrial fibrillation: a retrospective claims analysis

... and non-steroidal anti-inflammatory agents [NSAIDS]), heart rate control medications (beta-blockers, calcium channel blockers, digoxin/digitoxin), antiarrhythmic medications (dronedarone, amiodarone, disopyramide, ...

9

Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study

<p>Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study</p>

... and prevalence. Second, it was feasible to open and review only 200 charts. Therefore, the study population was selected from a list of individuals at highest risk. This method enabled the recognition of both positive ...

7

A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol

A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol

... Atrial fibrillation (AF) is the most common chronic car- diac arrhythmia, which often remains undiagnosed and is associated with a significantly increased risk for thrombo- embolic stroke [1 – ...

8

Rivaroxaban (Xarelto) for stroke prevention in non-valvular atrial fibrillation (riv-ah-rocks-ah-ban)

Rivaroxaban (Xarelto) for stroke prevention in non-valvular atrial fibrillation (riv-ah-rocks-ah-ban)

... 7. Singh P, et al. J Clin Pharm Ther 2011;36:166–71. 8. Wang L, et al. Curr Ther Res Clin Exp 2008;69:514–24. 9. eTG complete [online]. Atrial fibrillation (amended July 2012). http://www.tg.org.au ...

8

Evaluation of left atrial deformation to predict left atrial stasis in patients with non-valvular atrial fibrillation – a pilot-study

Evaluation of left atrial deformation to predict left atrial stasis in patients with non-valvular atrial fibrillation – a pilot-study

... left atrial deformation and a pro-thrombotic state in AF are based on ...left atrial strain rate was slightly higher than in other studies ...left atrial strain rate rather than strain with ...

9

Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients

Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients

... within non-diabetic level are an independent risk factor for CVD, especially coronary heart disease and ischaemic ...in non-diabetic Korean adult males ...in non-valvular AF patients, so it ...

5

Unlabeled Uses: Prevention of stroke and systemic embolism in patients with non valvular atrial fibrillation.

Unlabeled Uses: Prevention of stroke and systemic embolism in patients with non valvular atrial fibrillation.

... infarction; and individual components of the composite end points. The primary safety end point was a composite of major and nonmajor and clinically relevant bleeding events. The prima[r] ...

9

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

... with Atrial Fibrilla- tion: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm ...

5

Common Questions and Answers on the Practical Use of Oral Anticoagulants in Non-Valvular Atrial Fibrillation

Common Questions and Answers on the Practical Use of Oral Anticoagulants in Non-Valvular Atrial Fibrillation

... This information is a summary guide – for further information please consult individual SPCs at Version 1.2 March 2015 The following tables address these common questions..  How do o[r] ...

11

Show all 10000 documents...

Related subjects